全球支架置入和扩张器材市场：市场规模、份额和趋势分析（2025-2032 年）

2025年全球支架置入及扩张装置市场规模约6.89亿美元。预计到2031年，该市场规模将超过8.47亿美元，复合年增长率为3%。

该报告涵盖食道支架和扩张球囊、十二指肠支架和扩张球囊以及结肠支架和扩张球囊。胆道和胰管支架及扩张球囊在内视镜逆行性造影（ERCP）市场章节中单独分析。

它量化了销售量、平均售价（ASP）、市值、成长率和企业市场占有率，并深入分析了市场驱动因素和限制因素、併购、技术趋势等。报告提供了 2021 年至 2024 年的历史数据以及到 2031 年的预测。

该研究范围反映了技术创新、临床适应症的扩大和材料的进步如何持续影响世界各地胃肠道 (GI) 手术中产品的采用和性能。

市场概览

支架置入和扩张装置在治疗胃肠道狭窄和阻塞中发挥核心作用。这些装置用于恢復食道、十二指肠和结肠恶性及良性疾病患者的管腔通畅性，并缓解其症状。

近年来，随着医生们逐渐接受创伤较小的手术治疗方法，市场也取得了显着发展。置入术如今已成为过去主要依赖外科手术的病例的首选治疗方案。内视镜治疗方案日益偏好，这与医学界更广泛的理念转变不谋而合，即缩短住院时间、降低併发症风险并加快康復速度。

从裸金属支架到全覆膜自膨式金属支架（SEMS）的转变，标誌着支架安全性和可回收性显着提高的明显趋势。生物可吸收支架和药物释放型支架的研发正在拓展治疗方法选择，早期临床证据表明，这些支架能够提高患者耐受性并降低血管再阻塞率。

同时，扩张球囊作为狭窄治疗的辅助性治疗或单一疗法，其应用日益广泛。多级球囊系统可使用单一器械进行分阶段扩张，进而提高手术效率和疗效，进而提昇平均售价，并促进市场价值的成长。

总体而言，全球支架植入和扩张装置市场反映了临床疗效、材料创新和成本效益的整合，使这些技术成为微创治疗的关键推动因素。

市场驱动因素

拓展用途和适应症

医师对支架和扩张球囊的应用范围已从传统的肿瘤治疗扩展到良性食道狭窄、肥胖併发症和术后渗漏等新的治疗领域。临床研究表明，十二指肠置入术通常比外科手术治疗阻塞性狭窄创伤更小、成本更低，因此支持其在安宁疗护和根治性治疗中更广泛地应用。

随着医疗保健系统优先考虑以价值为导向的治疗结果，置入术已成为对成本敏感的患者和支付方的首选治疗方案。同样，人们对逆流相关疾病的认识不断提高，以及无需开放性手术即可加强薄弱组织的益处，也促使食道扩张球囊的应用日益广泛。

这些全球趋势正在推动全球手术量增加，尤其是在医疗系统正在加强内视镜检查能力的地区。

新技术

技术创新是全球支架置入和扩张器材市场的主要成长要素。全覆膜金属支架的引入提高了取出效率，减少了组织浸润，并降低了併发症率。到2025年，生物可吸收支架和药物释放型支架将从初步试验走向商业化应用，早期使用者报告称，这些支架能够改善患者的治疗效果。

材料科学的进步不断推动更轻、更强的合金和聚合物涂层的研发，从而增强支架的柔韧性和径向支撑力，同时最大限度地减少支架移位。这些市场发展趋势提高了手术成功率和长期通畅率，进而促进了市场的持续成长。

多级扩张球囊

外科医生越来越倾向于使用多阶段扩张球囊而不是单阶段设计，因为多阶段扩张球囊可以控制地逐步扩张狭窄处，临床研究表明，这可以减少组织损伤和穿孔风险，并提高管腔扩张的稳定性。

多级球囊系统比传统球囊系统更具价值，由于其卓越的安全性和有效性，正在主要市场广泛应用。随着此类球囊系统成为标准医疗设备，预计将提升整体市场价值，并推动高级产品细分市场的成长。

市场限制

儘管成长前景可观，但仍有几个因素限制着市场扩张。

成本压力和报销挑战

不同地区的保险报销结构差异显着，在一些新兴市场，胃肠道置入术的保险覆盖范围仍然有限。面临预算限制的医院通常优先考虑可重复使用和成本较低的方案，这降低了主动式支架（ASP）的成长潜力。

临床培训和设备使用

在资源匮乏的地区，高品质的内视镜实验室和训练有素的工作人员的取得并不稳定，复杂的支架置入手术的学习曲线可能会限制新技术的采用，尤其是生物可吸收支架。

装置迁移和併发症

儘管材料的改进减少了併发症，但支架移位和阻塞仍然是临床上需要关注的问题。这些问题会导致再次手术，增加治疗总成本，并影响患者对更成熟设计的偏好。

总体而言，市场成长高度依赖培训、证据产生和扩大报销范围，尤其是在新兴地区。

市场覆盖范围和数据范围

定量范围

市场规模、市占率、市场预测

成长率、销售量、平均售价（ASP）

定性范围

成长趋势、市场限制和技术进步

竞争分析、併购

公司简介及产品系列

手术数量和技术趋势

调查期

• 基准年：2025年
• 预测：2025-2032年
• 历史资料：2022-2024年

数据来源

对肠胃病学家和行业专家的初步访谈、监管和医院采购资料、进出口资料、iData Research 内部资料库

调查方法

市场收入模型是根据单位数量乘以平均售价 (ASP) 计算得出的，并使用每种支架和球囊类别的手术数据、使用率和交易假设检验。

目标市场及区隔

• 支架和扩张器市场－进一步细分为：

食道支架

十二指肠支架

结肠支架

食道扩张球囊

十二指肠扩张球囊

结肠扩张球囊

竞争分析

全球支架植入和扩张装置市场集中度适中，少数几家跨国公司占据了全球收入的大部分。

到2025年，波士顿科学公司将引领市场，占约50%的市场。波士顿科学公司丰富的内视镜配件产品组合使医院能够从单一供应商采购多个类别的设备，从而增强品牌忠诚度并简化采购流程。波士顿科学公司的支架技术因其临床可靠性和全球分销网络而广受认可。

库克医疗（Cook Medical）在2025年排名第二，在扩张球囊和特殊食道应用领域保持强大的市场地位。该公司提供三款食道球囊产品线，其中包括专为治疗贲门失弛症而设计的Quantum TTC®扩张球囊。库克医疗专注于此临床领域，使其能够供应全球大部分用于治疗食道动力障碍的球囊。

奥林巴斯公司已收购韩国胃肠道金属支架製造商泰雄医疗株式会社。此次收购将丰富奥林巴斯的产品线并拓展其分销网络，尤其是在欧洲地区。奥林巴斯的Niti-S™和COMVI™产品线包括用于食道、十二指肠和结肠的全覆膜和半覆膜支架。凭藉极具竞争力的价格和遍布25个国家的本地经销商网络，奥林巴斯的产品对注重成本的医疗机构极具吸引力。

其他活动包括在特定地域或产品类型上运作的区域性製造商。市场的集中性促使企业持续投资于品质、证据累积和产品差异化，同时也提高了新竞争者的进入门槛。

科技与临床趋势

由于全覆膜支架和药物释放型支架具有更好的可移除性和更少的组织浸润，它们正逐渐取代老式的裸金属支架。

生物可吸收支架技术尚处于早期应用阶段，在短期适应症方面展现出良好的应用前景。

由于其优异的安全性，多级扩张球囊正逐渐成为良性狭窄的标准治疗方法。

输送系统的改进可以实现更精确的定位，缩短手术时间，并减少透视辐射暴露。

材料创新，包括聚合物-金属混合框架，提高了径向力，同时最大限度地减少了患者的不适感。

临床重点正转向基于证据选择支架类型和覆盖范围，并以规范实践模式的国际指南为支持。

地区

本期内容涵盖全球范围，包括北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的详细分析。

调查方法附录与简称

目录

图表清单

图表列表

调查方法

全球关税的影响

支架置入及扩张装置市场

• 执行摘要
  • 全球支架置入和扩张装置市场概览
  • 竞争分析
  • 流程分段
  • 市场区隔
  • 目标区域
• 介绍
• 手术次数
  • 支架置入术
  • 隆乳手术
• 市场概览
  • 按细分市场
  • 按地区
• 市场分析与预测
  • 支架置入及扩张器材市场整体状况
  • 食道支架市场
  • 十二指肠支架市场
  • 结肠支架市场
  • 食道扩张球囊市场
  • 十二指肠扩张球囊市场
  • 结肠扩张球囊市场
• 驾驶员和约束装置
• 竞争市占率分析

简称

The global stenting and dilation device market was valued at approximately $689 million in 2025. The market is projected to grow at a compound annual growth rate (CAGR) of 3%, reaching more than $847 million by 2031.

This report covers esophageal stents and dilation balloons, duodenal stents and dilation balloons, and colonic stents and dilation balloons. Biliary and pancreatic stents and dilation balloons are analyzed separately under the endoscopic retrograde cholangiopancreatography (ERCP) market chapter.

The report quantifies units, average selling prices (ASPs), market values, growth rates, and company shares, and it provides a detailed analysis of market drivers and limiters, mergers and acquisitions, and technology trends. It includes historical data from 2021 to 2024 and forecasts to 2031.

The scope reflects how technological innovation, expanding clinical indications, and material advancements continue to shape product adoption and performance across gastrointestinal (GI) procedures worldwide.

Market Overview

Stenting and dilation devices are central to the management of strictures and obstructions within the gastrointestinal tract. These devices are used to restore luminal patency and relieve symptoms in patients with malignant and benign conditions of the esophagus, duodenum, and colon.

In recent years, the market has evolved significantly as physicians adopt less invasive alternatives to surgery. Stenting procedures now represent a primary treatment option in cases where surgical intervention once dominated. The growing preference for endoscopic solutions aligns with the medical community's broader shift toward shorter hospital stays, lower complication risks, and reduced recovery times.

The transition from bare-metal to fully covered self-expanding metal stents (SEMS) underscores a clear trend toward improved safety and retrievability. Developments in bioabsorbable and drug-eluting stents are expanding the therapeutic landscape, with early clinical evidence showing better patient tolerance and reduced restenosis rates.

Meanwhile, dilation balloons continue to gain traction as an adjunct or standalone therapy for stricture management. Multi-stage balloon systems that enable progressive dilation through a single device are improving procedural efficiency and outcomes, supporting stronger ASPs and contributing to market value growth.

Overall, the global stenting and dilation market reflects the convergence of clinical efficacy, material innovation, and cost-effectiveness, positioning these technologies as key enablers of minimally invasive care.

Market Drivers

Expansion of Uses and Indications

Physician adoption of stents and dilation balloons has expanded beyond traditional oncologic applications into new therapeutic areas, including benign esophageal strictures, bariatric complications, and post-surgical leaks. Clinical studies have demonstrated that duodenal stenting is often less invasive and more cost-effective than surgical alternatives for managing obstructive strictures, supporting its broader use in both palliative and curative settings.

As healthcare systems prioritize value-based outcomes, stenting has become a preferred treatment pathway for cost-sensitive patients and payers. Likewise, the adoption of esophageal dilation balloons continues to rise as awareness grows around reflux-related disorders and the benefits of reinforcing weakened tissue without open surgery.

These trends are expanding procedural volumes globally, particularly in regions where healthcare systems are strengthening endoscopic capabilities.

New Technologies

Innovation is a primary growth driver for the global stenting and dilation market. The introduction of fully covered metal stents has improved removal capability, reduced tissue ingrowth, and lowered complication rates. By 2025, bioabsorbable and drug-eluting stents had moved from pilot studies into commercial availability, with early adopters reporting improved patient outcomes.

Material science continues to advance, with lighter and stronger alloys and polymer coatings enhancing device flexibility and radial force while minimizing migration. These developments are improving procedural success and contributing to better long-term patency rates, fueling sustained market growth.

Multi-Stage Dilation Balloons

Surgeons increasingly prefer multi-stage dilation balloons over single-stage designs because they allow gradual, controlled dilation of strictures. This method has been clinically shown to reduce tissue trauma and perforation risk while improving lumen expansion consistency.

Although multi-stage systems carry higher ASPs than conventional balloons, their superior safety and effectiveness are driving adoption across major markets. As these devices become standard practice, they are expected to elevate overall market value and support the growth of the premium product segment.

Market Limiters

Despite promising growth, several factors continue to constrain broader market expansion.

Cost Pressures and Reimbursement Challenges

Reimbursement structures vary widely across regions, and in some developing markets, coverage for GI stenting procedures remains limited. Hospitals facing budget constraints often prioritize reusable or lower-cost options, reducing ASP growth potential.

Clinical Training and Access to Equipment

In lower-resource regions, access to high-quality endoscopy suites and trained personnel remains inconsistent. The learning curve for complex stenting procedures can limit adoption, particularly for emerging technologies like bioabsorbable stents.

Device Migration and Complications

While material improvements have reduced complications, stent migration and occlusion remain clinical concerns. These issues can lead to repeat procedures, increasing total cost of care and influencing product preference toward more established designs.

Overall, market growth depends heavily on training, evidence generation, and reimbursement expansion, particularly in emerging regions.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, and market forecasts

Growth rates, units sold, and average selling prices (ASPs)

Qualitative Coverage

Growth trends, market limiters, and technology advancements

Competitive analysis, mergers and acquisitions

Company profiles and product portfolios

Procedure numbers and technology trends shaping adoption

Time Frame

• Base year: 2025
• Forecasts: 2025-2032
• Historical data: 2022-2024

Data Sources

Primary interviews with gastroenterologists and industry experts, regulatory and hospital procurement data, import and export data, and the iData Research internal database.

Method Note

Market revenues are modeled from units multiplied by ASP, validated with procedural data, utilization rates, and replacement assumptions for each stent and balloon category.

Markets Covered and Segmentation

• Stenting & Dilation Device Market - Further Segmented Into:

Esophageal Stent

Duodenal Stent

Colonic Stent

Esophageal Dilation Balloon

Duodenal Dilation Balloon

Colonic Dilation Balloon

Competitive Analysis

The global stenting and dilation device market is moderately concentrated, with a few multinational firms accounting for the majority of global revenue.

Boston Scientific led the market in 2025, holding approximately 50% of total market share. The company's broad endoscopic accessories portfolio enables hospitals to source multiple device categories from a single vendor, reinforcing brand loyalty and simplifying procurement. Boston Scientific's stent technologies are widely recognized for their clinical reliability and global distribution reach.

Cook Medical ranked second in 2025, maintaining a strong presence in dilation balloons and specialized esophageal applications. The company offers three esophageal balloon lines, including Quantum TTC(R) dilation balloons, designed specifically for treating achalasia. Through its focus on this clinical niche, Cook Medical supplies a large proportion of balloons used for esophageal motility disorders worldwide.

Olympus Corporation held the third-largest position, strengthened by its acquisition of Taewoong Medical Co., Ltd., a South Korean manufacturer of GI metallic stents. This acquisition expanded Olympus's product range and geographic reach, especially across Europe. The company's Niti-S(TM) and COMVI(TM) product lines include fully and partially covered stents for esophageal, duodenal, and colonic use. Olympus's competitive pricing and partnerships with national distributors across 25 countries make its portfolio appealing to cost-conscious healthcare systems.

Other participants include regional manufacturers active in limited geographies or product types. The concentrated nature of the market encourages continued investment in quality, evidence generation, and product differentiation, while raising the entry barrier for new competitors.

Technology and Practice Trends

Fully covered and drug-eluting stents are replacing older bare-metal designs due to improved removability and reduced tissue ingrowth.

Bioabsorbable stent technologies are in early adoption stages, showing promise for temporary indications.

Multi-stage dilation balloons are becoming standard for benign strictures due to superior safety outcomes.

Improved delivery systems now allow more precise placement, reducing procedural time and fluoroscopy exposure.

Material innovation, including hybrid polymer-metal frameworks, is enhancing radial force while minimizing patient discomfort.

Clinical focus is shifting toward evidence-based selection of stent type and coverage, supported by international guidelines that standardize practice patterns.

Geography

This edition provides global coverage, including detailed breakdowns for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology Appendix and Acronym Glossary

Why This Report

Where are the largest and fastest-growing opportunities within the global stenting and dilation device market, and which categories are expected to gain share through 2031?

How are technological innovations, including bioabsorbable materials and drug-eluting designs, reshaping product performance and clinical decision-making?

What are the economic and procedural trends influencing adoption across regions, and how do reimbursement models affect market potential?

How are training access, material advancements, and patient safety outcomes influencing hospital purchasing decisions?

Which product types and manufacturers are most strongly positioned to benefit from the ongoing shift toward minimally invasive GI therapies?

How can suppliers leverage multi-stage balloon innovations and next-generation stent designs to strengthen their market position and pricing strategy?

The Global Stenting & Dilation Device Market Report from iData Research answers these questions with procedure-aware modeling, company share analysis, and price benchmarking. Use it to quantify demand, plan portfolio strategy, guide pricing decisions, and identify the next phase of global growth opportunities.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Stenting & Dilation Market

• 6.1 Executive Summary
  • 6.1.1 Global Stenting & Dilation Market Overview
  • 6.1.2 Competitive Analysis
  • 6.1.3 Procedure Segmentation
  • 6.1.4 Market Segmentation
  • 6.1.5 Regions Included
• 6.2 Introduction
• 6.3 Procedure Numbers
  • 6.3.1 Stenting Procedures
    • 6.3.1.1 Esophageal Stenting Procedures
    • 6.3.1.2 Duodenal Stenting Procedures
    • 6.3.1.3 Colonic Stenting Procedures
  • 6.3.2 Dilation Procedures
    • 6.3.2.1 Esophageal Dilation Procedures
    • 6.3.2.2 Duodenal Dilation Procedures
    • 6.3.2.3 Colonic Dilation Procedures
• 6.4 Market Overview
  • 6.4.1 By Segment
  • 6.4.2 By Region
• 6.5 Market Analysis And Forecast
  • 6.5.1 Total Stenting & Dilation Market
  • 6.5.2 Esophageal Stent Market
    • 6.5.2.1 Covered-Metal Esophageal Stent Market
    • 6.5.2.2 Bare-Metal Esophageal Stent Market
    • 6.5.2.3 Plastic Esophageal Stent Market
  • 6.5.3 Duodenal Stent Market
  • 6.5.4 Colonic Stent Market
  • 6.5.5 Esophageal Dilation Balloon Market
  • 6.5.6 Duodenal Dilation Balloon Market
  • 6.5.7 Colonic Dilation Balloon Market
• 6.6 Drivers And Limiters
  • 6.6.1 Market Drivers
  • 6.6.2 Market Limiters
• 6.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 6-1: Stenting & Dilation Market, Global, 2025 & 2032
• Chart 6-2: Stenting & Dilation Procedures, Global, 2025
• Chart 6-3: Stenting & Dilation Procedures by Segment, Global, 2022 - 2032
• Chart 6-4: Stenting & Dilation Procedures by Segment, Global, 2022 - 2032
• Chart 6-5: Stenting & Dilation Market by Segment, Global, 2022 - 2032
• Chart 6-6: Stenting & Dilation Market by Region, Global, 2022 - 2032
• Chart 6-7: Leading Competitors, Stenting & Dilation Market, Global, 2025

LIST OF FIGURES

• Figure 6-1: Stenting & Dilation Procedure Segmentation
• Figure 6-2: Stenting & Dilation Market Segmentation
• Figure 6-3: Stenting & Dilation Regions Covered, Global (1 of 2)
• Figure 6-4: Stenting & Dilation Regions Covered, Global (2 of 2)
• Figure 6-5: Stenting and Dilation Procedures by Segment, Global, 2022 - 2032
• Figure 6-6: Stenting & Dilation Procedures by Region, Global, 2022 - 2032
• Figure 6-7: Stenting & Dilation Procedures by Country, North America, 2022 - 2032
• Figure 6-8: Stenting & Dilation Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-9: Stenting & Dilation Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-10: Stenting & Dilation Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-11: Stenting & Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-12: Stenting & Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-13: Stenting & Dilation Procedures by Country, Middle East, 2022 - 2032
• Figure 6-14: Stenting & Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-15: Stenting & Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-16: Stenting & Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-17: Stenting & Dilation Procedures by Country, Africa, 2022 - 2032
• Figure 6-18: Stenting Procedures by Segment, Global, 2022 - 2032
• Figure 6-19: Stenting Procedures by Region, Global, 2022 - 2032
• Figure 6-20: Stenting Procedures by Country, North America, 2022 - 2032
• Figure 6-21: Stenting Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-22: Stenting Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-23: Stenting Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-24: Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-25: Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-26: Stenting Procedures by Country, Middle East, 2022 - 2032
• Figure 6-27: Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-28: Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-29: Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-30: Stenting Procedures by Country, Africa, 2022 - 2032
• Figure 6-31: Esophageal Stenting Procedures by Region, Global, 2022 - 2032
• Figure 6-32: Esophageal Stenting Procedures by Country, North America, 2022 - 2032
• Figure 6-33: Esophageal Stenting Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-34: Esophageal Stenting Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-35: Esophageal Stenting Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-36: Esophageal Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-37: Esophageal Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-38: Esophageal Stenting Procedures by Country, Middle East, 2022 - 2032
• Figure 6-39: Esophageal Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-40: Esophageal Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-41: Esophageal Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-42: Esophageal Stenting Procedures by Country, Africa, 2022 - 2032
• Figure 6-43: Duodenal Stenting Procedures by Region, Global, 2022 - 2032
• Figure 6-44: Duodenal Stenting Procedures by Country, North America, 2022 - 2032
• Figure 6-45: Duodenal Stenting Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-46: Duodenal Stenting Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-47: Duodenal Stenting Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-48: Duodenal Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-49: Duodenal Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-50: Duodenal Stenting Procedures by Country, Middle East, 2022 - 2032
• Figure 6-51: Duodenal Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-52: Duodenal Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-53: Duodenal Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-54: Duodenal Stenting Procedures by Country, Africa, 2022 - 2032
• Figure 6-55: Colonic Stenting Procedures by Region, Global, 2022 - 2032
• Figure 6-56: Colonic Stenting Procedures by Country, North America, 2022 - 2032
• Figure 6-57: Colonic Stenting Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-58: Colonic Stenting Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-59: Colonic Stenting Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-60: Colonic Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-61: Colonic Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-62: Colonic Stenting Procedures by Country, Middle East, 2022 - 2032
• Figure 6-63: Colonic Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-64: Colonic Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-65: Colonic Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-66: Colonic Stenting Procedures by Country, Africa, 2022 - 2032
• Figure 6-67: Dilation Procedures by Segment, Global, 2022 - 2032
• Figure 6-68: Dilation Procedures by Region, Global, 2022 - 2032
• Figure 6-69: Dilation Procedures by Country, North America, 2022 - 2032
• Figure 6-70: Dilation Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-71: Dilation Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-72: Dilation Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-73: Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-74: Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-75: Dilation Procedures by Country, Middle East, 2022 - 2032
• Figure 6-76: Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-77: Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-78: Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-79: Dilation Procedures by Country, Africa, 2022 - 2032
• Figure 6-80: Esophageal Dilation Procedures by Region, Global, 2022 - 2032
• Figure 6-81: Esophageal Dilation Procedures by Country, North America, 2022 - 2032
• Figure 6-82: Esophageal Dilation Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-83: Esophageal Dilation Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-84: Esophageal Dilation Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-85: Esophageal Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-86: Esophageal Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-87: Esophageal Dilation Procedures by Country, Middle East, 2022 - 2032
• Figure 6-88: Esophageal Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-89: Esophageal Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-90: Esophageal Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-91: Esophageal Dilation Procedures by Country, Africa, 2022 - 2032
• Figure 6-92: Duodenal Dilation Procedures by Region, Global, 2022 - 2032
• Figure 6-93: Duodenal Dilation Procedures by Country, North America, 2022 - 2032
• Figure 6-94: Duodenal Dilation Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-95: Duodenal Dilation Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-96: Duodenal Dilation Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-97: Duodenal Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-98: Duodenal Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-99: Duodenal Dilation Procedures by Country, Middle East, 2022 - 2032
• Figure 6-100: Duodenal Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-101: Duodenal Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-102: Duodenal Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-103: Duodenal Dilation Procedures by Country, Africa, 2022 - 2032
• Figure 6-104: Colonic Dilation Procedures by Region, Global, 2022 - 2032
• Figure 6-105: Colonic Dilation Procedures by Country, North America, 2022 - 2032
• Figure 6-106: Colonic Dilation Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 6-107: Colonic Dilation Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 6-108: Colonic Dilation Procedures by Country, Western Europe, 2022 - 2032
• Figure 6-109: Colonic Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 6-110: Colonic Dilation Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 6-111: Colonic Dilation Procedures by Country, Middle East, 2022 - 2032
• Figure 6-112: Colonic Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 6-113: Colonic Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 6-114: Colonic Dilation Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 6-115: Colonic Dilation Procedures by Country, Africa, 2022 - 2032
• Figure 6-116: Stenting & Dilation Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 6-117: Stenting & Dilation Market by Region, Global, 2022 - 2032 (US$M)
• Figure 6-118: Stenting & Dilation Market, Global, 2022 - 2032
• Figure 6-119: Units Sold by Region, Stenting & Dilation Market, Global, 2022 - 2032
• Figure 6-120: Average Selling Price by Region, Stenting & Dilation Market, Global, 2022 - 2032 (US$)
• Figure 6-121: Market Value by Region, Stenting & Dilation Market, Global, 2022 - 2032 (US$M)
• Figure 6-122: Esophageal Stent Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 6-123: Total Esophageal Stent Market, Global, 2022 - 2032
• Figure 6-124: Units Sold by Region, Esophageal Stent Market, Global, 2022 - 2032
• Figure 6-125: Average Selling Price by Region, Esophageal Stent Market, Global, 2022 - 2032 (US$)
• Figure 6-126: Market Value by Region, Esophageal Stent Market, Global, 2022 - 2032 (US$M)
• Figure 6-127: Covered-Metal Esophageal Stent Market, Global, 2022 - 2032
• Figure 6-128: Units Sold by Region, Covered-Metal Esophageal Stent Market, Global, 2022 - 2032
• Figure 6-129: Average Selling Price by Region, Covered-Metal Esophageal Stent Market, Global, 2022 - 2032 (US$)
• Figure 6-130: Market Value by Region, Covered-Metal Esophageal Stent Market, Global, 2022 - 2032 (US$M)
• Figure 6-131: Bare-Metal Esophageal Stent Market, Global, 2022 - 2032
• Figure 6-132: Units Sold by Region, Bare-Metal Esophageal Stent Market, Global, 2022 - 2032
• Figure 6-133: Average Selling Price by Region, Bare-Metal Esophageal Stent Market, Global, 2022 - 2032 (US$)
• Figure 6-134: Market Value by Region, Bare-Metal Esophageal Stent Market, Global, 2022 - 2032 (US$M)
• Figure 6-135: Plastic Esophageal Stent Market, Global, 2022 - 2032
• Figure 6-136: Units Sold by Region, Plastic Esophageal Stent Market, Global, 2022 - 2032
• Figure 6-137: Average Selling Price by Region, Plastic Esophageal Stent Market, Global, 2022 - 2032 (US$)
• Figure 6-138: Market Value by Region, Plastic Esophageal Stent Market, Global, 2022 - 2032 (US$M)
• Figure 6-139: Duodenal Stent Market, Global, 2022 - 2032
• Figure 6-140: Units Sold by Region, Duodenal Stent Market, Global, 2022 - 2032
• Figure 6-141: Average Selling Price by Region, Duodenal Stent Market, Global, 2022 - 2032 (US$)
• Figure 6-142: Market Value by Region, Duodenal Stent Market, Global, 2022 - 2032 (US$M)
• Figure 6-143: Colonic Stent Market, Global, 2022 - 2032
• Figure 6-144: Units Sold by Region, Colonic Stent Market, Global, 2022 - 2032
• Figure 6-145: Average Selling Price by Region, Colonic Stent Market, Global, 2022 - 2032 (US$)
• Figure 6-146: Market Value by Region, Colonic Stent Market, Global, 2022 - 2032 (US$M)
• Figure 6-147: Esophageal Dilation Balloon Market, Global, 2022 - 2032
• Figure 6-148: Units Sold by Region, Esophageal Dilation Balloon Market, Global, 2022 - 2032
• Figure 6-149: Average Selling Price by Region, Esophageal Dilation Balloon Market, Global, 2022 - 2032 (US$)
• Figure 6-150: Market Value by Region, Esophageal Dilation Balloon Market, Global, 2022 - 2032 (US$M)
• Figure 6-151: Duodenal Dilation Balloon Market, Global, 2022 - 2032
• Figure 6-152: Units Sold by Region, Duodenal Dilation Balloon Market, Global, 2022 - 2032
• Figure 6-153: Average Selling Price by Region, Duodenal Dilation Balloon Market, Global, 2022 - 2032 (US$)
• Figure 6-154: Market Value by Region, Duodenal Dilation Balloon Market, Global, 2022 - 2032 (US$M)
• Figure 6-155: Colonic Dilation Balloon Market, Global, 2022 - 2032
• Figure 6-156: Units Sold by Region, Colonic Dilation Balloon Market, Global, 2022 - 2032
• Figure 6-157: Average Selling Price by Region, Colonic Dilation Balloon Market, Global, 2022 - 2032 (US$)
• Figure 6-158: Market Value by Region, Colonic Dilation Balloon Market, Global, 2022 - 2032 (US$M)
• Figure 6-159: Leading Competitors, Stenting & Dilation Market, Global, 2025